Significant Ownership of GENERAL ATLANTIC, L.P.

Large-stake snapshot 1 signal
Large-stake filing summary
  • Recent SEC Schedule 13D/G filings for GENERAL ATLANTIC, L.P. focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
/s/ Michael Gosk - Michael Gosk, Managing Director
Manager location
New York, NY

Follow Filing Activity

Follow GENERAL ATLANTIC, L.P. and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Significant Ownership of GENERAL ATLANTIC, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DLO dLocal Ltd Class A common shares, nominal value $0.002 per share 28% $485,229,628 46,656,695 GENERAL ATLANTIC, L.P. 05 Sep 2025
ALKT ALKAMI TECHNOLOGY, INC. Common stock, par value $0.001 per share 18% $344,722,644 +$35,056,250 19,420,994 +11% General Atlantic, L.P. 13 May 2026
Liftoff Mobile, Inc. Common stock, par value $0.0001 per share 15% 25,315,646 GENERAL ATLANTIC, L.P. 05 Jun 2026
AKRO Akero Therapeutics, Inc. Common Stock, par value $0.0001 per share 8.4% $278,656,049 6,796,489 General Atlantic, L.P. 31 Mar 2025
ALHC Alignment Healthcare, Inc. Class A common stock, par value $0.001 per share 6.6% $280,209,358 -$236,622,832 13,167,733 -46% GENERAL ATLANTIC, L.P. 31 Dec 2025
CHYM Chime Financial, Inc. Class A Common Stock, par value $0.0001 per share 5.6% $387,440,689 19,208,760 General Atlantic, L.P. 13 Jun 2025
XP XP Inc. Class A common shares, par value US$0.00001 per share 5.4% $434,238,534 22,758,833 GENERAL ATLANTIC, L.P. 02 Dec 2025
RPRX Royalty Pharma plc Class A ordinary shares, par value US$0.0001 per share 3.2% $510,500,301 14,243,870 General Atlantic, L.P. 30 Jun 2025
ADAG Adagene Inc. Ordinary shares, par value US$0.0001 per share 0% $0 0 General Atlantic Singapore Fund Pte. Ltd. 31 Dec 2025
THRD Third Harmonic Bio, Inc. Common stock, par value $0.0001 0% $0 -$18,663,136 0 -100% General Atlantic, L.P. 11 Feb 2025
BLND Blend Labs, Inc. Class A common stock, par value $0.00001 per share 0% $0 0 General Atlantic, L.P. 31 Dec 2024

Schedules 13D/G Reported by GENERAL ATLANTIC, L.P.:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .